F. Schlemmer
YOU?
Author Swipe
View article: Bronchiectasis in France: data on disease characteristics in 630 patients from the European Bronchiectasis registry (EMBARC)
Bronchiectasis in France: data on disease characteristics in 630 patients from the European Bronchiectasis registry (EMBARC) Open
In France, adults with bronchiectasis experience significant disease burden. Respiratory exacerbations are responsible for healthcare utilization and their prevention may require specialized multidisciplinary care and the development of no…
View article: French national protocol for diagnosis and management of drug reaction with eosinophilia and systemic symptoms (DRESS) in adults and children
French national protocol for diagnosis and management of drug reaction with eosinophilia and systemic symptoms (DRESS) in adults and children Open
International audience
View article: Corrigendum to “Human metapneumovirus infection is associated with a substantial morbidity and mortality burden in adult inpatients” [Heliyon Volume 10, Issue 13, July 15, 2024, Article e33231]
Corrigendum to “Human metapneumovirus infection is associated with a substantial morbidity and mortality burden in adult inpatients” [Heliyon Volume 10, Issue 13, July 15, 2024, Article e33231] Open
[This corrects the article DOI: 10.1016/j.heliyon.2024.e33231.].
View article: Acid sphingomyelinase deficiency in France: a retrospective survival study
Acid sphingomyelinase deficiency in France: a retrospective survival study Open
View article: Human metapneumovirus infection is associated with a substantial morbidity and mortality burden in adult inpatients
Human metapneumovirus infection is associated with a substantial morbidity and mortality burden in adult inpatients Open
View article: French national protocol for diagnosis and management of epidermal necrolysis in adults (Stevens-Johnson syndrome and toxic epidermal necrolysis)
French national protocol for diagnosis and management of epidermal necrolysis in adults (Stevens-Johnson syndrome and toxic epidermal necrolysis) Open
View article: Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials Open
View article: COPD after “Tabouna” Exposure: A Distinct Phenotype in Tunisian Women?
COPD after “Tabouna” Exposure: A Distinct Phenotype in Tunisian Women? Open
Background: COPD due to exposure to combustible biomass is an increasingly recognized phenotype, particularly among women who use traditional ovens, known as ‘Tabouna’, for baking bread. This paper aims to investigate the clinical and func…
View article: Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort Open
Background Longitudinal cohort data of patients with tuberculosis (TB) and coronavirus disease 2019 (COVID-19) are lacking. In our global study, we describe long-term outcomes of patients affected by TB and COVID-19. Methods We collected d…
View article: Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre study
Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre study Open
Background Survivors of severe-to-critical coronavirus disease 2019 (COVID-19) may have functional impairment, radiological sequelae and persistent symptoms requiring prolonged follow-up. This pragmatic study aimed to describe their clinic…
View article: The telomerase activator TA-65 protects from cigarette smoke-induced small airway remodeling in mice through extra-telomeric effects
The telomerase activator TA-65 protects from cigarette smoke-induced small airway remodeling in mice through extra-telomeric effects Open
Small airway remodeling (SAR) is a key phenomenon of airflow obstruction in smokers, leading to chronic obstructive pulmonary disease (COPD). SAR results in an increased thickness of small airway walls, with a combination of peribronchiola…
View article: Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group Open
View article: Identification of factors impairing exercise capacity after severe COVID-19 pulmonary infection: a 3-month follow-up of prospective COVulnerability cohort
Identification of factors impairing exercise capacity after severe COVID-19 pulmonary infection: a 3-month follow-up of prospective COVulnerability cohort Open
Background Patient hospitalized for coronavirus disease 2019 (COVID-19) pulmonary infection can have sequelae such as impaired exercise capacity. We aimed to determine the frequency of long-term exercise capacity limitation in survivors of…
View article: Determinants of a bronchoalveolar lavage of good quality for mineralogical analyses in adults: Experience from the Asbestos Fibers and Particles Laboratory of Paris City
Determinants of a bronchoalveolar lavage of good quality for mineralogical analyses in adults: Experience from the Asbestos Fibers and Particles Laboratory of Paris City Open
View article: Interstitial lung diseases associated with mutations of poly(A)‐specific ribonuclease: A multicentre retrospective study
Interstitial lung diseases associated with mutations of poly(A)‐specific ribonuclease: A multicentre retrospective study Open
Background and objective Poly(A)‐specific ribonuclease ( PARN ) mutations have been associated with familial pulmonary fibrosis. This study aims to describe the phenotype of patients with interstitial lung disease (ILD) and heterozygous PA…
View article: Apport de la technique de double diffusion DLCO-DLNO dans l’évaluation des séquelles fonctionnelles respiratoires post-COVID
Apport de la technique de double diffusion DLCO-DLNO dans l’évaluation des séquelles fonctionnelles respiratoires post-COVID Open
View article: Functional Ex Vivo Testing of Alveolar Monocytes in Patients with Pneumonia-Related ARDS
Functional Ex Vivo Testing of Alveolar Monocytes in Patients with Pneumonia-Related ARDS Open
Biomarkers of disease severity might help with individualizing the management of patients with acute respiratory distress syndrome (ARDS). During sepsis, a sustained decreased expression of the antigen-presenting molecule human leucocyte a…
View article: Impact of a rare respiratory diseases reference centre set-up on primary ciliary dyskinesia care pathway
Impact of a rare respiratory diseases reference centre set-up on primary ciliary dyskinesia care pathway Open
International audience
View article: Management of early infection with Pseudomonas aeruginosa in adults with bronchiectasis: A survey of French pulmonologist's practices
Management of early infection with Pseudomonas aeruginosa in adults with bronchiectasis: A survey of French pulmonologist's practices Open
View article: Etiological Work-Up for Adults with Bronchiectasis: A Predictive Diagnostic Score for Primary Ciliary Dyskinesia and Cystic Fibrosis
Etiological Work-Up for Adults with Bronchiectasis: A Predictive Diagnostic Score for Primary Ciliary Dyskinesia and Cystic Fibrosis Open
Background: etiological investigations are not done for all adult patients with bronchiectasis because of the availability and interpretation of tests. The aim of the study was to elaborate a score to identify patients at high risk of havi…
View article: Pneumonies virales épidémiques – Pneumonie à SARS-CoV-2 : où en sommes-nous ?
Pneumonies virales épidémiques – Pneumonie à SARS-CoV-2 : où en sommes-nous ? Open
View article: Un « @-CPLF » sous le règne de la COVID-19
Un « @-CPLF » sous le règne de la COVID-19 Open
View article: Correction to: Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 disease
Correction to: Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 disease Open
View article: Continuous positive airway pressure for respiratory support during COVID-19 pandemic: a frugal approach from bench to bedside
Continuous positive airway pressure for respiratory support during COVID-19 pandemic: a frugal approach from bench to bedside Open
View article: Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial Open
View article: Alveolar compartmentalization of inflammatory and immune cell biomarkers in pneumonia-related ARDS
Alveolar compartmentalization of inflammatory and immune cell biomarkers in pneumonia-related ARDS Open
Background Biomarkers of disease severity might help individualizing the management of patients with the acute respiratory distress syndrome (ARDS). Whether the alveolar compartmentalization of biomarkers has a clinical significance in pat…
View article: TB and COVID-19 co-infection: rationale and aims of a global study
TB and COVID-19 co-infection: rationale and aims of a global study Open
International audience
View article: Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 disease
Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 disease Open
View article: Bronchoalveolar Lavage in Patients with COVID-19 with Invasive Mechanical Ventilation for Acute Respiratory Distress Syndrome
Bronchoalveolar Lavage in Patients with COVID-19 with Invasive Mechanical Ventilation for Acute Respiratory Distress Syndrome Open
View article: Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia Open
ClinicalTrials.gov Identifier: NCT04331808.